JON S. TIGAR, District Judge.
Defendants Novartis Consumer Health, Inc., by and through its undersigned attorneys ("Defendant"), and Plaintiffs Julie Winkelmann, Michelle Cruz, and Thamar S. Cortina, by and through their undersigned attorneys ("Plaintiffs"), hereby stipulate to the following:
WHEREAS, on January 10, 2014, Plaintiffs filed a complaint captioned Winkelmann et al. v. Novartis AG et al., No. 14-cv-160, a purported class action under Cal. Bus. & Prof. Code § 17200;
WHEREAS, on April 3, 2014, Plaintiffs amended their complaint by (1) adding an additional plaintiff and (2) dismissing without prejudice defendants Novartis AG and Novartis Corporation;
WHEREAS, pursuant to the January 16, 2014 Case Management Conference Order (Dkt. #10), the Initial Case Management Conference is scheduled for April 23, 2014;
WHEREAS lead counsel for Defendant is unable to participate in the Case Management Conference on April 23 as he will be in Philadelphia for a deposition on that date;
WHEREAS lead counsel for Defendant and Plaintiffs are able to participate in a Case Management Conference on May 7, 2014;
WHEREAS this stipulation is without prejudice to, or waiver of, any rights, arguments, or defenses otherwise available to the parties in this action, including, but not limited to, challenges to jurisdiction or venue.
NOW THEREFORE, the undersigned parties, by and though their counsel of record, stipulate as follows:
1. The Initial Case Management Conference, currently scheduled for April 23, 2014, is hereby adjourned to May 7, 2014 or such other later date as is convenient for the Court.
2. Case Management Statements shall be due ten court days prior to the new Case Management Conference date.
PURSUANT TO STIPULATION, IT IS SO ORDERED.